Skip to main content
Apt Medical Inc. logo

Apt Medical Inc. — Investor Relations & Filings

Ticker · 688617 ISIN · CNE100004C45 Shanghai Stock Exchange Manufacturing
Filings indexed 662 across all filing types
Latest filing 2022-03-02 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688617

About Apt Medical Inc.

https://www.aptmed.com/

Apt Medical Inc. is a specialized developer and manufacturer of advanced medical devices for minimally invasive vascular interventions. The company focuses on the fields of electrophysiology, interventional cardiology, and peripheral vascular procedures. Its product portfolio includes diagnostic and ablation catheters, steerable sheaths, guide wires, microcatheters, and balloon catheters designed for complex cardiovascular treatments. Apt Medical emphasizes research and development to provide high-precision tools for clinicians, aiming to improve procedural outcomes in the treatment of cardiac arrhythmias and vascular diseases. The company serves a global market, providing integrated solutions for interventional procedures through a commitment to technological innovation and quality manufacturing standards.

Recent filings

Filing Released Lang Actions
关于自愿披露取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the voluntary disclosure of obtaining a medical device registration certificate by a subsidiary. It includes product information, impact on the company, and risk warnings. The document is short (852 characters) and does not contain financial statements or detailed financial data. It is an announcement of a regulatory approval event rather than a financial report or detailed management information. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is a regulatory announcement about a product registration, which aligns best with Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2022-03-02 Chinese
关于变更签字注册会计师的公告
Audit Report / Information Classification · 95% confidence The document is an announcement from Shenzhen Huitai Medical Devices Co., Ltd. regarding a change in the signing certified public accountant for the 2021 annual audit. It details the replacement of one signing auditor with another and confirms the independence and qualifications of the new auditor. The document does not contain the audit report itself, nor does it include financial statements or substantive financial data. It is a regulatory announcement about auditor personnel changes related to the audit process. Therefore, it fits best under Audit Report / Information (AR) as it relates to audit information but is not the full annual report or audit report itself. The document length is short and focused on audit personnel change, not a full report or certification letter, so it is not Regulatory Filings (RNS). FY 2021
2022-02-24 Chinese
2021年度业绩快报公告
Earnings Release Classification · 95% confidence The document is titled '2021 年度业绩快报公告' which translates to '2021 Annual Performance Express Report Announcement'. It contains preliminary financial data for the year 2021, including revenue, profit, and asset figures, but explicitly states that the data is unaudited and subject to the final audited annual report. The document is relatively short (2326 characters) and serves as a quick performance update rather than a full annual report. It also includes explanations of changes and risk warnings, typical of an earnings release or performance summary. Given the length and content, it fits the definition of an Earnings Release (ER) rather than a full Annual Report (10-K) or Interim Report (IR). FY 2021
2022-02-24 Chinese
关于自愿披露取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from Shenzhen Huitai Medical Devices Co., Ltd. about voluntarily disclosing the acquisition of medical device registration certificates. It includes product information, impact on the company, and risk warnings. The document is only 1017 characters long and does not contain any financial statements, detailed financial data, or comprehensive report content. It is an announcement of a regulatory or product approval event rather than a financial report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-02-21 Chinese
2021年年度业绩预告
Earnings Release Classification · 95% confidence The document is a performance forecast announcement for the fiscal year 2021, providing preliminary estimated net profit figures and explanations for changes compared to the previous year. It explicitly states that the forecast has not been audited and that the final audited financial data will be disclosed in the formal annual report. The document length is short (1104 characters) and it does not contain actual audited financial statements or detailed financial analysis. It is a forward-looking earnings preview rather than a full earnings release or annual report. Therefore, it fits best as an Earnings Release (ER) type, which covers initial announcements of quarterly or periodical financial results with key highlights only. FY 2021
2022-01-27 Chinese
股东减持股份计划公告
Transaction in Own Shares Classification · 95% confidence The document is a detailed announcement regarding a shareholder share reduction plan by major shareholders and senior management of Shenzhen Huitai Medical Device Co., Ltd. It includes specifics about shareholding percentages, planned reduction quantities, methods, periods, and related commitments and risks. The content focuses on the shareholders' intentions to reduce their holdings and the regulatory compliance of such actions. There is no financial data, earnings information, or report publication mentioned. The document is not a report itself but an official announcement about shareholding changes by insiders and major shareholders. This fits the definition of a Transaction in Own Shares (POS) filing, which covers company buybacks or sales of its own shares or share reduction plans by shareholders. Therefore, the correct classification is POS with high confidence.
2022-01-26 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.